Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
10 min read
CLOVES syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 CLOVES syndrome indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Klippel-Trenaunay syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Klippel-Trenaunay syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Sturge-Weber syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Sturge-Weber syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Tuberous sclerosis complex-associated epilepsy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Tuberous sclerosis complex-associated epilepsy strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Latest Hotspot
10 min read
Tuberous sclerosis complex renal angiomyolipoma Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Tuberous sclerosis complex renal angiomyolipoma strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Latest Hotspot
10 min read
SMARCB1-related schwannomatosis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 SMARCB1-related schwannomatosis strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Neurofibromatosis type 2-related schwannomatosis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Neurofibromatosis type 2-related schwannomatosis strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built.
Latest Hotspot
10 min read
Neurofibromatosis type 1 plexiform neurofibroma Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Neurofibromatosis type 1 plexiform neurofibroma strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Latest Hotspot
10 min read
Legius syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Legius syndrome indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Cardiofaciocutaneous syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Cardiofaciocutaneous syndrome strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Costello syndrome Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Costello syndrome indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Noonan syndrome with multiple lentigines Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Noonan syndrome with multiple lentigines strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.